Antibiotic resistant infections and multi-drug resistant infections have been on the rise in recent years. When it comes to sepsis, these infections have the potential to be much more dangerous because they can be difficult to treat.
Sepsis is the body’s life-threatening, imbalanced response to a severe infection. The condition affects 1.7 million people and takes 270,000 lives in the U.S. every year. This year, we face additional risks because of the threat of COVID-19.
Three well-established infectious diseases—Tuberculosis, malaria, and HIV—are poised to kill millions worldwide, with decades of healthcare progress that could be lost due to disruptions caused by COVID-19. Even under normal circumstances, the toll these three diseases exact worldwide is staggering.
A study published in June 2019 found that combining rapid blood culture identification (BCID) testing with antimicrobial stewardship initiatives yielded a decrease in broad spectrum antibiotic use.